FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells Source: Eur Respir J 2009; 33: 425-435 Year: 2009
Serum thymic stromal lymphopoietin level depends on allergic profile in pediatric asthma Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies Year: 2021
Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018
IL-4Ra signaling is required for thymic stromal lymphopoietin (TSLP)-induced type 2 airway inflammation Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Analysing disease-specific variants of thymic stromal lymphopoietin (TSLP) in asthma Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015
Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march Source: Eur Respir Rev 2014; 23: 292-298 Year: 2014
Blockade of thymic stromal lymphopoietin receptor (TSLPR) reduces atopic inflammation in a cynomolgus monkey model of asthma Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012
YS3: Thymic stromal lymphopoietin is a central regulator of anti-viral CD8+ T cell responses Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011
Thymic stromal lymphopoietin (TSLP) in naturally occurring asthma exacerbations in adults Source: International Congress 2016 – New findings in mucosal immunology Year: 2016
Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Inhaled antibodies: targeting tumour necrosis factor receptor 1 and thymic stromal lymphopoietin Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019
Thymic stromal lymphopoietin (TSLP) as a local biomarker of hypertrophic changes in the synonasal mucosa in children with atopic bronchial asthma (BA) and allergic rhinitis (AR) Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Thymic stromal lymphopoietin promotes asthmatic airway remodeling in human lung fibroblast cells through stat3 signaling pathway Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012
Thymic stromal lymphopoietin (TSLP), an innate immunity initiator of Th2 inflammatory responses, is induced by viral stimuli in asthmatic epithelium. Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Vanadium pentoxide induced epithelial innate cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) through activating MAPK pathway Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018
Peripheral blood Th17 and Th17/Th2 cells and their association with lung function and biomarkers in asthma-COPD overlap syndrome Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Expression of IL-16 in peripheral blood stem cell-derived human basophils Source: Eur Respir J 2006; 28: Suppl. 50, 337s Year: 2006
CD6 is expressed on human airway and blood innate lymphoid cells (ILCs) and is upregulated by epithelial alarmins IL-33 and TSLP Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
Epithelial derived cytokines IL-25, IL-33 and TSLP in obstructive lung diseases Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
LSC Abstract – Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016